Detalhe da pesquisa
1.
The use of zoledronic acid in men receiving androgen deprivation therapy for prostate cancer with severe osteopenia or osteoporosis.
Urology
; 75(5): 1138-43, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20303574